MEDIFARMSOFT

Booth E19

#906, Tower B, H Business Park 25, Beobwon-ro 11-gil, Songpa-gu, Seoul, Republic of Korea

Since our foundation in 2018, Medifarmsoft has been developing and providing ambulatory ECG device and AI software that reads and analyzes ECG measured without medical staff’s help all over the world. We are very proud of ourselves by developing the world’s first AI algorithm which can read 18 kinds of heart diseases in 2019. We specialize in researching and developing next generation medical services, and we aim to become the leading experts in AI-based biometric information system. We provide a biometric data analysis service by measuring very easily various biometric signal including ECG anywhere, anytime using an artificial intelligence-based automatic heart disease reading platform. As a result, we can prevent from sudden death by heart disease and arrhythmia.